Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data

por Long, Gráinne H., Tatro, Amanda R., Oh, Young S., Reddy, Sheila R., Ananthakrishnan, Ashwin N.
Publicado 2019

Etrolizumab for the Treatment of Ulcerative Colitis and Crohn’s Disease: An Overview of the Phase 3 Clinical Program

por Sandborn, William J., Vermeire, Severine, Tyrrell, Helen, Hassanali, Azra, Lacey, Stuart, Tole, Swati, Tatro, Amanda R.
Publicado 2020

Replicating prediction algorithms for hospitalization and corticosteroid use in patients with inflammatory bowel disease

por Gan, Ryan W., Sun, Diana, Tatro, Amanda R., Cohen-Mekelburg, Shirley, Wiitala, Wyndy L., Zhu, Ji, Waljee, Akbar K.
Publicado 2021